Suzhou Highfine Biotech Co., Ltd. Class A 301393
SZSE · China · Process Industries
CNY 67.13+1.23 (+1.87%)
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CNY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
In recent weeks, Asia's markets have been navigating a complex landscape marked by geopolitical tensions and fluctuating energy prices. Despite these challenges, opportunities for growth persist, particularly in the small-cap segment where nimble companies can capitalize on emerging trends and resilient economic indicators. Identifying promising stocks in such an environment often involves looking for companies with strong fundamentals that are poised to benefit from regional economic...
As global markets grapple with concerns over AI disruption and mixed economic signals, small-cap stocks have shown resilience, with the S&P MidCap 400 Index experiencing a relatively modest decline compared to larger indices. In this environment, identifying promising small-cap companies can be crucial for investors seeking growth opportunities; these undiscovered gems often exhibit strong fundamentals and innovative potential that may not yet be fully recognized by the broader market.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.